Target intelligence / Profile preview

Amyloid beta precursor protein binding protein 2 (APPBP2)

Target
APPBP2
Molecular classification
Substrate recognition receptor (E3 ubiquitin ligase CRL2 complex), Protein-coding gene, Microtubule-associated protein
01

Overview

Amyloid beta precursor protein binding protein 2 (APPBP2) is a highly conserved, multi-domain protein that acts as a substrate recognition receptor within the Cullin 2-RING ubiquitin ligase complex (CRL2). It specifically recognizes C-terminal R-x-x-G degron motifs in substrate proteins, leading to targeted ubiquitin-mediated degradation. APPBP2 interacts with microtubules, regulates the transport and processing of beta-amyloid precursor protein—a protein implicated in Alzheimer's disease—and is linked to cancer biology. Structural insight has established its role in protein turnover and provided a foundation for the design of small-molecule ligands such as PROTACs for selective degradation of pathological targets[2][4][5]. Overexpression of APPBP2 has clinical relevance as a biomarker in several cancer types.

Other names
APPBP2Amyloid beta precursor protein binding protein 2Amyloid precursor protein binding protein 2Roadblock-1
02

Mechanism of action

Drugs or PROTACs targeting APPBP2 typically function by promoting ubiquitin-mediated degradation of proteins via recognition of C-degron motifs

03

Biological functions

Protein degradation via ubiquitin-proteasome pathway (DesCEND, C-degron mediated)Transport and processing of beta-amyloid precursor protein (APP)Regulation of cell deathMicrotubule motor activity
04

Disease associations

Cancer (highly expressed in breast cancer, associated with ovarian clear cell adenocarcinoma, Li-Fraumeni Syndrome 1)Neurodegenerative disease (by regulating beta-amyloid precursor protein, APP, involved in Alzheimer's disease biology)
05

Safety considerations

Not explicitly detailed; risks may include off-target protein degradation or disruption of APP-related cell processes (potential neurotoxicity or cytotoxicity if hijacked therapeutically)
06

Biomarkers

Over-expression may be a biomarker in breast cancerInvolvement in beta-amyloid biology suggests possible relevance in Alzheimer's disease

Beyond the preview

Go deeper on Amyloid beta precursor protein binding protein 2 (APPBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid beta precursor protein binding protein 2 (APPBP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call